Trade, Intellectual Property & Health Diplomacy
Coursalytics is an independent platform to find, compare, and book executive courses. Coursalytics is not endorsed by, sponsored by, or otherwise affiliated with Graduate Institute of International and Development Studies.Full disclaimer.
Twenty years after the creation of the World Trade Organization,trade liberalisation is moving forward through bilateral and regional trade agreements. Not only are the number of trade agreements increasing, but the content of these agreements is also evolving. Initially, agreements focused on traditional trade, areas such as tariffs, services, and intellectual property. The debate about the role of intellectual property in pharmaceutical innovation has evolved and progress has been made, for example, through increased use of licensing agreements and patent pooling, as well as through the use of the remaining political flexibilities to adapt national intellectual property systems to individual country needs. But the launch of new, high-priced treatments for hepatitis C, cancer and orphan diseases has also fuelled the debate about what constitutes a fair price. New issues have emerged, such as the lack of investment in the development of new antibiotics and treatments for pathogens with pandemic potential.
Other traditional elements, such as investor-to-state arbitration,have suddenly emerged as threats to national health policy. New health measures to counter the increasing disease burden in non-communicable diseases - through the reduction of “bad” fat, sugar and salt in foods and beverages, and reduced tobacco consumption – are often in conflict with trade policies and agreements. Other global agreements and areas, such as the new WTO Agreement on Trade Facilitation, have the potential to facilitate access to affordable health products but are broadly overlooked by the health community.
Ministries of health are facing the challenge of coping with the potential adverse impact of trade agreements on national health policies and strategies. Ministries of trade must be aware of how and why trade policy impacts public health. How can ministries of health and trade work together to seize opportunities and formulate a positive agenda for such negotiations and how can they avoid national health measures from conflicting with international trade rules?
Intensive three-day course with renowned faculty and leading practitioners
Combine theory and practice through lectures, panel discussions, working group exercises and a negotiation simulation
Meet in the world's global health capital
This course will introduce participants to the interface of trade, intellectual property and public health policies and increase participants’ understanding of these intersections. The course will include the following topics:
- The interface of intellectual property, trade, and global public health policies: Key concepts, actors, and challenges
- The dynamics of negotiations related to intellectual property, trade and global health, including how to influence such negotiations
- Challenges of balancing innovation and access to medical products
- Challenges and perspectives for the future
The course is highly participatory, drawing on the national and international professional experiences of participants through a multi-disciplinary learning process. It includes:
- Multi-stakeholder panels
- Lectures by internationally-renowned experts and negotiators
- Case studies
- Working groups
- An evening negotiation simulation
Who should attend
- Health and international relations professionals in departments of international health, ministries of health, foreign affairs, trade and development cooperation
- Representatives from international, regional and non-governmental organisations
- Professionals in philanthropic organisations, the private sector and academia